Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IGF-1R/AS ODN |
Synonyms | |
Therapy Description |
IGF-1R/AS ODN is an antisense oligodeoxynucleotide against the Insulin-like growth factor 1 receptor (IGF1R), which when exposed to autologous tumor cells and implanted promotes the release of exosomes with tumor associated antigens to induce an immune based anti-tumor response (PMID: 25391690). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IGF-1R/AS ODN | IGF-1R Inhibitor 17 | IGF-1R/AS ODN is an antisense oligodeoxynucleotide against the Insulin-like growth factor 1 receptor (IGF1R), which when exposed to autologous tumor cells and implanted promotes the release of exosomes with tumor associated antigens to induce an immune based anti-tumor response (PMID: 25391690). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02507583 | Phase I | IGF-1R/AS ODN | Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma | Completed | USA | 0 |